£520.00

It has never been this cheap. We have no record of a lower price.

£520 today · cheaper than every other day in the last 3 months

The 2023-2028 Outlook for Antidepressant and Anti-Anxiety Drugs in the United States

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 37 days · 37 data points (no recent data)

Historical
Generating forecast…
£520.00 £494.00 £504.40 £514.80 £525.20 £535.60 £546.00 22 August 2026 31 August 2026 09 September 2026 18 September 2026 27 September 2026
View at Amazon ↗

Price data last checked 54 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 37 days • 1 price levels

Days at Price
37 days 0 9 19 28 37 £520 Days at Price

Price Analysis

Most common price: £520 (37 days, 100.0%)

Price range: £520 - £520

Price levels: 1 different prices over 37 days

Description

This study covers the latent demand outlook for antidepressant and anti-anxiety drugs across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 12,600 cities in the United States. For each city in question, the percent share the city is of its state and of the United States as a whole is reported. These comparative benchmarks allow the reader to quickly gauge a city vis-à-vis others. This statistical approach can prove very useful to distribution and/or sales force strategies. Using econometric models which project fundamental economic dynamics within each state and city, latent demand estimates are created for antidepressant and anti-anxiety drugs. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of antidepressant and anti-anxiety drugs as including all commonly understood products and/or services falling within this broad category, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include Acadia Pharmaceuticals, Actelion, Alkermes, Allergan, Aptinyx, AstraZeneca, Avineuro Pharmaceuticals, Axsome Therapeutics, Azevan Pharmaceuticals, Bausch Health, BioLite, BlackThorn Therapeutics, Bristol - Myers Squibb (BMS), Cerecor, Denovo Biopharma, Eli Lilly and Company, Fabre-Kramer Pharmaceuticals, Forest Laboratories, GlaxoSmithKline, H. Lundbeck, Intra-Cellular Therapies, Janssen Pharmaceutica, Johnson & Johnson, Lupin Pharmaceuticals, Luye Pharma (USA), Ltd., Marinus Pharmaceuticals, Medtronic, PLC, Minerva Neurosciences, MSI Methylation Sciences, Neuralstem, Nobilis Therapeutics, Otsuka Pharmaceutical Company, Pfizer, Pherin Pharmaceuticals, Proteus Digital Health, Reviva Pharmaceuticals, Sage Therapeutics, Sandong Luye Pharmaceutical Company, Ltd., Sunovion Pharmaceuticals, Supernus Pharmaceuticals, Suven Life Sciences, Taisho Pharmaceutical, Takeda Pharmaceutical Company, Teva Pharmaceuticals Industries, Tonix Pharmaceuticals, Valeant Pharmaceuticals, and VistaGen Therapeutics. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2022).

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
26 October 2022
Listed Since
09 November 2022

Similar Products You Might Like

The 2023-2028 Outlook for Pharmaceuticals for US Zip Codes
90% match

The 2023-2028 Outlook for Pharmaceuticals for US Zip Codes

£490.00 27 Sep 2026
The 2023-2028 Outlook for Chronic Disease Management Therapeutics and Device Technologies in the United States
90% match

The 2023-2028 Outlook for Chronic Disease Management Therapeutics and Device Technologies in the United States

£520.00 27 Sep 2026
The 2023-2028 Outlook for Antifungal Drugs in India
90% match

The 2023-2028 Outlook for Antifungal Drugs in India

£515.00 27 Sep 2026
The 2023-2028 Outlook for Chemotherapy-Induced Serotonin Receptor Antagonists for Nausea and Vomiting Drugs in India
90% match

The 2023-2028 Outlook for Chemotherapy-Induced Serotonin Receptor Antagonists for Nausea and Vomiting Drugs in India

£515.00 27 Sep 2026
The 2023-2028 Outlook for Neurology in the United States
90% match

The 2023-2028 Outlook for Neurology in the United States

£520.00 27 Sep 2026
The 2023-2028 Outlook for Antiemetic Chemotherapy Drugs in India
90% match

The 2023-2028 Outlook for Antiemetic Chemotherapy Drugs in India

£515.00 27 Sep 2026
The 2023-2028 Outlook for Nucleotide Polymerase Inhibitor Antiviral Drugs in the United States
89% match

The 2023-2028 Outlook for Nucleotide Polymerase Inhibitor Antiviral Drugs in the United States

£520.00 27 Sep 2026
The 2023-2028 Outlook for Biologic Vasculitis Treatments in the United States
89% match

The 2023-2028 Outlook for Biologic Vasculitis Treatments in the United States

£520.00 27 Sep 2026
The 2023-2028 Outlook for Anti-Inflammatory Asthma Drugs in India
89% match

The 2023-2028 Outlook for Anti-Inflammatory Asthma Drugs in India

£515.00 27 Sep 2026
The 2023-2028 Outlook for Pain Management Therapeutics for US Zip Codes
89% match

The 2023-2028 Outlook for Pain Management Therapeutics for US Zip Codes

£490.00 27 Sep 2026
The 2023-2028 Outlook for Laxatives for US Zip Codes
89% match

The 2023-2028 Outlook for Laxatives for US Zip Codes

£490.00 27 Sep 2026
The 2023-2028 Outlook for Animal Pharmaceuticals in the United States
89% match

The 2023-2028 Outlook for Animal Pharmaceuticals in the United States

£520.00 27 Sep 2026
The 2023-2028 World Outlook for Chemotherapy-Induced Serotonin Receptor Antagonists for Nausea and Vomiting Drugs
89% match

The 2023-2028 World Outlook for Chemotherapy-Induced Serotonin Receptor Antagonists for Nausea and Vomiting Drugs

£795.00 15 Sep 2026
The 2023-2028 Outlook for Antioxidants for US Zip Codes
89% match

The 2023-2028 Outlook for Antioxidants for US Zip Codes

£490.00 27 Sep 2026
The 2023-2028 Outlook for Nocturia Drugs for US Zip Codes
89% match

The 2023-2028 Outlook for Nocturia Drugs for US Zip Codes

£490.00 27 Sep 2026
The 2023-2028 Outlook for Cognitive and Memory Enhancer Drugs for US Zip Codes
89% match

The 2023-2028 Outlook for Cognitive and Memory Enhancer Drugs for US Zip Codes

£490.00 27 Sep 2026
The 2023-2028 Outlook for Orphan Biologic Drugs in India
89% match

The 2023-2028 Outlook for Orphan Biologic Drugs in India

£515.00 27 Sep 2026
The 2023-2028 Outlook for Anticholinergic Motion Sickness Treatments in India
89% match

The 2023-2028 Outlook for Anticholinergic Motion Sickness Treatments in India

£515.00 27 Sep 2026
The 2023-2028 Outlook for Peripheral Neuropathy Treatments for US Zip Codes
89% match

The 2023-2028 Outlook for Peripheral Neuropathy Treatments for US Zip Codes

£490.00 27 Sep 2026
The 2023-2028 Outlook for Pain Management Drugs and Devices for US Zip Codes
89% match

The 2023-2028 Outlook for Pain Management Drugs and Devices for US Zip Codes

£490.00 27 Sep 2026
The 2023-2028 World Outlook for Pharma Contract Sales
89% match

The 2023-2028 World Outlook for Pharma Contract Sales

£795.00 15 Sep 2026
The 2023-2028 Outlook for Anti-Viral Nucleotide Polymerase Inhibitor Drugs for US Zip Codes
89% match

The 2023-2028 Outlook for Anti-Viral Nucleotide Polymerase Inhibitor Drugs for US Zip Codes

£490.00 27 Sep 2026
The 2023-2028 Outlook for Pruritus Corticosteroid Therapeutics in India
89% match

The 2023-2028 Outlook for Pruritus Corticosteroid Therapeutics in India

£515.00 27 Sep 2026
The 2023-2028 Outlook for Thyroid Gland Disorders Treatments in the United States
89% match

The 2023-2028 Outlook for Thyroid Gland Disorders Treatments in the United States

£520.00 27 Sep 2026